Page last updated: 2024-09-03

esonarimod and sq-23377

esonarimod has been researched along with sq-23377 in 1 studies

Compound Research Comparison

Studies
(esonarimod)
Trials
(esonarimod)
Recent Studies (post-2010)
(esonarimod)
Studies
(sq-23377)
Trials
(sq-23377)
Recent Studies (post-2010) (sq-23377)
33184,38510493

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukushima, K; Inoue, T; Takeshita, K1

Other Studies

1 other study(ies) available for esonarimod and sq-23377

ArticleYear
Effects of KE-758; an active metabolite of the new anti-rheumatic drug KE-298, D-penicillamine, bucillamine and auranofin on the proliferation of murine lymphocytes, and the production of nitric oxide by murine macrophages.
    International immunopharmacology, 2001, Volume: 1, Issue:5

    Topics: Animals; Antirheumatic Agents; Auranofin; Cell Division; Cell Line; Concanavalin A; Cysteine; Female; Hydrogen Peroxide; In Vitro Techniques; Interferon-gamma; Ionomycin; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred DBA; Nitric Oxide; Penicillamine; Phenylpropionates; Recombinant Proteins; Tetradecanoylphorbol Acetate

2001